The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Longitudinal Study of Symptoms in Colorectal Cancer
Official Title: Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Study ID: NCT00777192
Brief Summary: The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
Detailed Description: If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled visit. The questionnaires are designed to measure pain and other symptoms, your mood, and your quality of life. You will also give a tissue sample by inserting a cotton tipped swab into your mouth and rubbing firmly against the inside of your cheek or underneath your lower or upper lip for about 1 minute at the most. Completing the 5 questionnaires and the swab sample should take about 30 minutes. Length of Study: After you complete the questionnaires and the swab sample collection, your active participation in this study will be over. This is an investigational study. Up to 500 patients will take part in this study. All will be enrolled at MD Anderson.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Name: Xin Shelley Wang, MD. MPH
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR